InVid Flaunts Violating FDA Guidelines

By Charles Rollet, Published Aug 28, 2020, 07:48am EDT

InVid Tech is showcasing an open violation of FDA fever screening guidelines by touting "simultaneous detection of fevers" despite explicit FDA instructions to "measure only one" person at a time.

IPVM Image

InVid Tech stood by this open violation, telling IPVM "people want to know the functions of our product, and that is what we are telling them." Of course, this is not InVid's product but a relabel of Sunell's Pandacam (that we have tested here).

This adds to Invid Tech previously falsely claiming its fever products were not medical devices despite the FDA clearly stating such products are.

In this post, we examine this incident and why this increases public safety risk.

What ********

** ** ****** ** marketing *****, ***** **** included **** ***** ******* its ********* ******'***** ***':

IPVM Image

Open *** *********

****** **********,****** * ****** *** in ***, ******* ***** "******* only ***" ****** ** a ****:

IPVM Image

********* "******** ****** ** the **** ****" *** "not **** ***** ** be ********", *** *** states:

IPVM Image

*** *** **** **** that ***** **** ********* issues (**** *** ****** enough ******, *** ******) when ********* ******** ****** and **** **** **** not ***** ** *** studies ******* **** ********* multiple ****** *** ********. Separately,* ********** ****** ******** told *********** **** ** ** "top **** ******" ******** to *** ******* ** be ********, ******* "******** doesn't *** ****** ******." Moreover, ********* *** ************* ******* ********* *** person ** * ****.

Sunell **** ****** ************ *********

*** '************ *********' ***** is *** **** ** Sunell ** **** ** part ** ***'***** ***'*********:

IPVM Image

Problems ** ******** ****** *********

***** ***** *** ****** market ******** ****** *********, Sunell's ****** ************ ********* that, *.*.:

IPVM Image

* *** ****** **** Sunell *** ***** ****** publicly ******* ** **** this ****** **** ******** the *********** ** *** forehead ** ** *** forehead ** ******* ** any *** (**** * cap ** **** ** one's **** ******* ****), the ****** **** ***** typically **** * '******' temperature *** **** **** elevated ************.

********, ***** *** ****** does *** **** ******* to **** *** ***** canthus (***** ****** *********** and ****** ********* *** clear ***** *********), *** system ******* ********** ********.

** ***** / ****** can **** **** ****** at **** *** ** will **** **** '******' temperatures *** ** *** risk ** *** ********* people **** ***** ******** temperatures / '******'.

Stock ***** ********* ***** **** *****

*** ***** ** *** people *** ***** *********** ******** *** ******* image ******:

IPVM Image

**** ********* *** ******** trend ** ****** ***** screening *****, *.*. ******** ********* ********* ********* ads *** ***** ****.

InVid **** ********

**** ******** ***** ****'* president*** ************ *** *** ********* and ** ***** ** the *********:

IPVM Image

***, ** ** **** a ********. *** ******** is **** *** ****** is ******* ** ******** simultaneous ****** ** * time. *** ******** ** there, *** **** ** what ** *** ******* people ****.

** ****** ********* *** advise ****** ** ****** the ********** *** ** by *** ********** *** authorities. ****** **** ** know *** ********* ** our *******, *** **** is **** ** *** telling ****.

**** ***** *** **** any ******** ** ***** Tech ******** ******** "****** to ****** *** **********" and ** ***** ***** for **** ********* *** they *** *** ******* on ****.

InVid ****'* *** ******** ***** ******

** **** ******** ** May, ***** **** ********** claimed *** ***** ********* products "** *** ******* as ******* *******", ***** is ***** (****** ******"***************** ******* **** ****** the ********** ** * device **** **** *** intended *** * ******* purpose"). ***** **** **** changed*** *************** *** ***** ***** products "*** *** *** approved ******* *******", ***** is *********** ******* ******** these ******** *** ***** medical ******* **** ******* FDA ********.

IPVM Image

****** *** **** ******** ** "**** *** intend ** ******" ** these *******' ***** **** as **** ** **** are **** "***** *** circumstances ********* ** *** guidance *** ***** **** use **** *** ****** undue ****".

**********

***** ****'* **** *** violation ***** **** ********** *** ************* ** ***** *** guidelines. *******, ****** ****** is ** **** **** these *********.

Comments (5)

*** ***** **** *** of ***** *******? ****** for * “*******-****” *****/**** photo **** *** ***** well *** ***-************ *****.

Agree
Disagree
Informative
Unhelpful
Funny

* *** **** **** sold * ***, *.*., back ** *****, * was ****** ***** *********** they *** ******* **** 40 ** ***** *****, I ***** ******* **** have **** ** ** 50 ***** **** ** the * ****** *****.

** **** ***, * believe ***** ** ****** many ******** ** ******* off ** ******* ****, which ** ***** ***** for * ***** ******* like ****. **** **** early, **** **** ***** an ******* ********* *** FDA ********** *** ****** safety, ****** **** ********* of *** ******** *** the **** ** ******.

Agree: 2
Disagree
Informative: 4
Unhelpful
Funny

** ***** *** **** to ***** **** ********* "multiple ****** ** *** same ****" *** "**** shown ** ************" **** ******** ** screening *** ******?

Agree
Disagree
Informative
Unhelpful
Funny

*** ******* **** ********* multiple ****** ** **** is **** *** ****** averages *** ************ ******* the *****'* ****, **** people **** **** ************ will ** ************* *** people **** *** ************ will ** ************; **** much *** **** **** admitted ** ** ** the *** ** * camera ************.

Agree
Disagree
Informative: 1
Unhelpful
Funny

*******, ***** *** ******* but **** ***** ***** supplier****** *** *** **** an *** ******* ******.

Agree
Disagree
Informative
Unhelpful
Funny
Read this IPVM report for free.

This article is part of IPVM's 6,887 reports, 921 tests and is only available to members. To get a one-time preview of our work, enter your work email to access the full article.

Already a member? Login here | Join now
Loading Related Reports